<bill session="116" type="h" number="985" updated="2019-07-30T13:16:19Z">
  <state datetime="2019-02-05">REFERRED</state>
  <status>
    <introduced datetime="2019-02-05"/>
  </status>
  <introduced datetime="2019-02-05"/>
  <titles>
    <title type="official" as="introduced">To amend the Federal Food, Drug, and Cosmetic Act to ensure that eligible product developers have competitive access to approved drugs and licensed biological products, so as to enable eligible product developers to develop and test new products, and for other purposes.</title>
    <title type="short" as="introduced">Fair Access for Safe and Timely Generics Act of 2019</title>
    <title type="short" as="introduced">Fair Access for Safe and Timely Generics Act of 2019</title>
    <title type="short" as="introduced">FAST Generics Act of 2019</title>
    <title type="short" as="introduced">FAST Generics Act of 2019</title>
    <title type="display">FAST Generics Act of 2019</title>
  </titles>
  <sponsor bioguide_id="W000800"/>
  <cosponsors>
    <cosponsor bioguide_id="C001090" joined="2019-03-11"/>
    <cosponsor bioguide_id="C001084" joined="2019-02-05"/>
    <cosponsor bioguide_id="M001180" joined="2019-02-05"/>
    <cosponsor bioguide_id="S001208" joined="2019-05-20"/>
  </cosponsors>
  <actions>
    <action datetime="2019-02-05">
      <text>Introduced in House</text>
    </action>
    <action datetime="2019-02-05" state="REFERRED">
      <text>Referred to the House Committee on Energy and Commerce.</text>
    </action>
  </actions>
  <committees>
    <committee subcommittee="" code="HSIF" name="House Energy and Commerce" activity="Referral"/>
  </committees>
  <relatedbills/>
  <subjects>
    <term name="Health"/>
    <term name="Competition and antitrust"/>
    <term name="Drug safety, medical device, and laboratory regulation"/>
    <term name="Licensing and registrations"/>
    <term name="Prescription drugs"/>
  </subjects>
  <amendments/>
  <committee-reports/>
</bill>
